Simona F Spampinato

Dr. Simona F Spampinato

Department of Biomedical and Biotechnological Sciences (BIOMETEC), Section of PharmacologyUniversity of Catania, Via Santa Sofia 97, 95123, Catania, Italy
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Simona F SpampinatoSimona F Spampinato
Simona F Spampinato
GCGrazia Ilaria Caruso
Grazia Ilaria Caruso
RPRocco De Pasquale
Rocco De Pasquale
MSMaria Angela Sortino
Maria Angela Sortino
SMSara Merlo
Sara Merlo
Chronic wounds often occur in patients with diabetes mellitus due to the impairment of wound healing. This has negative consequences for both the patient and the medical system and considering the growing prevalence of diabetes, it will be a significant medical, social, and economic burden in the near future. Hence, the need for therapeutic alternatives to the current available treatments that, although various, do not guarantee a rapid and definite reparative process, appears necessary. We here analyzed current treatments for wound healing, but mainly focused the attention on few classes of drugs that are already in the market with different indications, but that have shown in preclinical and few clinical trials the potentiality to be used in the treatment of impaired wound healing. In particular, repurposing of the antiglycemic agents dipeptidylpeptidase 4 (DPP4) inhibitors and metformin, but also, statins and phenyotin have been analyzed. All show encouraging results in the treatment of chronic wounds, but additional, well designed studies are needed to allow these drugs access to the clinics in the therapy of impaired wound healing.

1 January 2017 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
PDF file
YTYukio Takeshita
Yukio Takeshita
BOBirgit Obermeier
Birgit Obermeier
ACAnne C. Cotleur
Anne C. Cotleur
Simona F SpampinatoSimona F Spampinato
Simona F Spampinato
FSFumitaka Shimizu
Fumitaka Shimizu
RRRichard M. Ransohoff
Richard M. Ransohoff
Objective: To address the hypothesis that physiologic interactions between astrocytes and endothelial cells (EC) at the blood–brain barrier (BBB) are afflicted by pathogenic inflammatory signaling when astrocytes are exposed to aquaporin-4 (AQP4) antibodies present in the immunoglobulin G (IgG) fraction of serum from patients with neuromyelitis optica (NMO), referred to as NMO-IgG. Methods: We established static and flow-based in vitro BBB models incorporating co-cultures of conditionally immortalized human brain microvascular endothelial cells and human astrocyte cell lines with or without AQP4 expression. Results: In astrocyte–EC co-cultures, exposure of astrocytes to NMO-IgG decreased barrier function, induced CCL2 and CXCL8 expression by EC, and promoted leukocyte migration under flow, contingent on astrocyte expression of AQP4. NMO-IgG selectively induced interleukin (IL)-6 production by AQP4-positive astrocytes. When EC were exposed to IL-6, we observed decreased barrier function, increased CCL2 and CXCL8 expression, and enhanced leukocyte transmigration under flow. These effects were reversed after application of IL–6 neutralizing antibody. Conclusions: Our results indicate that NMO-IgG induces IL-6 production by AQP4-positive astrocytes and that IL-6 signaling to EC decreases barrier function, increases chemokine production, and enhances leukocyte transmigration under flow.

1 April 2018 in Pharmacological Research
Verified
Journal Article
Closed access
FCFilippo Caraci
Filippo Caraci
Simona F SpampinatoSimona F Spampinato
Simona F Spampinato
Maria Grazia MorgeseMaria Grazia Morgese
Maria Grazia Morgese
FTFabio Tascedda
Fabio Tascedda
MSMaria Grazia Salluzzo
Maria Grazia Salluzzo
ACAgata Copani
Agata Copani

1 June 2015 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
BPBriana Prager
Briana Prager
Simona F SpampinatoSimona F Spampinato
Simona F Spampinato
RRRichard M. Ransohoff
Richard M. Ransohoff

17 January 2019 in Cells
Verified
Journal Article
Open access
PDF file
Giuseppe CarusoGiuseppe Caruso
Giuseppe Caruso
CFClaudia Giuseppina Fresta
Claudia Giuseppina Fresta
Nicolò MussoNicolò Musso
Nicolò Musso
MGMariaconcetta Giambirtone
Mariaconcetta Giambirtone
MGMargherita Grasso
Margherita Grasso
FCFilippo Caraci
Filippo Caraci
Carnosine (β-alanyl-L-histidine), a dipeptide, is an endogenous antioxidant widely distributed in excitable tissues like muscles and the brain. Carnosine is involved in cellular defense mechanisms against oxidative stress, including the inhibition of amyloid-beta (Aβ) aggregation and the scavenging of reactive species. Microglia play a central role in the pathogenesis of Alzheimer’s disease, promoting neuroinflammation through the secretion of inflammatory mediators and free radicals. However, the effects of carnosine on microglial cells and neuroinflammation are not well understood. In the present work, carnosine was tested for its ability to protect BV-2 microglial cells against oligomeric Aβ1-42-induced oxidative stress and inflammation. Carnosine prevented cell death in BV-2 cells challenged with Aβ oligomers through multiple mechanisms. Specifically, carnosine lowered the oxidative stress by decreasing NO and O2−• intracellular levels as well as the expression of iNOS and Nox enzymes. Carnosine also decreased the secretion of pro-inflammatory cytokines such as IL-1β, simultaneously rescuing IL-10 levels and increasing the expression and the release of TGF-β1. Carnosine also prevented Aβ-induced neurodegeneration in mixed neuronal cultures challenged with Aβ oligomers, and these neuroprotective effects were completely abolished by SB431542, a selective inhibitor of the type-1 TGF-β receptor. Our data suggest a multimodal mechanism of action of carnosine underlying its protective effects on microglial cells against Aβ toxicity with a key role of TGF-β1 in mediating these protective effects.

31 August 2011 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
FCFilippo Caraci
Filippo Caraci
Simona F SpampinatoSimona F Spampinato
Simona F Spampinato
MSMaria Angela Sortino
Maria Angela Sortino
PBPaolo Bosco
Paolo Bosco
GBGiuseppe Battaglia
Giuseppe Battaglia
ACAgata Copani
Agata Copani